ESR2 and non-small cell lung carcinoma: In line with this, ERα and ERβ immunohistochemistry expression in 317 NSCLCs samples showed an increased expression of both receptors, suggesting that the expression of ERα and ERβ identifies a specific subpopulation of NSCLC with distinct clinicopathologic and genetic characteristics [104].